XW133F8Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8

  • Billable / Specific Code
ICD-10-PCS XW133F8
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

XW133F8 is a billable ICD-10-PCS procedure code for Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 016, 017. The root operation Transfusion involves putting in blood or blood products.

Code Identity

ICD-10-PCS Code
XW133F8
Billable Status
Yes — Valid for Submission
Code Describes
Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
Parent Code
Short Description
Transfuse OTL-103 in Periph Vein, Perc, New Tech 8

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation1Transfusion
4BodyPart3Peripheral Vein
5Approach3Percutaneous
6Device/Substance/TechnologyFOTL-103
7Qualifier8New Technology Group 8

Code History

Replaces previously assigned code(s):
  • 30233C0 — Transfuse Autol HSPC, Gene Mod in Periph Vein, Perc

Similar Procedure Codes

Questions About XW133F8

Is XW133F8 a billable code?

Yes. XW133F8 is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XW133F8 mean?

XW133F8 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character F is the Device/Substance/Technology (OTL-103); the 7th character 8 is the Qualifier (New Technology Group 8).

What MS-DRG does XW133F8 group to?

On an inpatient stay, Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8 maps to MS-DRGs 016, 017, with relative weights from 4.8383 to 5.9297. The MS-DRG sets the fixed Medicare payment for the stay.